<DOC>
	<DOCNO>NCT02788916</DOCNO>
	<brief_summary>The purpose study establish distribution peripheral T-cell lymphocyte ( PTCL ) subtypes re-analysis re-classification sample accord 2008 World Health Organization ( WHO ) classification lymphoid neoplasm .</brief_summary>
	<brief_title>A Retrospective Study Clinical , Phenotypic Genetic Factors Peripheral T-Cell Lymphomas</brief_title>
	<detailed_description>This study retrospective , non-interventional , post-authorization observational study design ( PAS-OD ) . This multicenter trial conduct Spain . Retrospective review medical record initial tumor biopsy participant diagnose PTCL period 6 year 01/01/2008 31/12/2013 perform . Initial tumor biopsy histological preparation , file previously anonymized , sent central laboratory assessment .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Peripheral</mesh_term>
	<criteria>Participants diagnose PTCL six year 01/01/2008 31/12/2013 . Availability initial tumor biopsy diagnosis paraffin block ( node core biopsy 1618mm ) . PTCL subtypes permit WHO 2008 classification lymphoid neoplasm : Natural killer/ Tlymphocytes ( NK /Tcell ) lymphoma extranodal nasal type Enteropathic Tcell lymphoma Hepatosplenic Tcell lymphoma Peripheral Tcell lymphoma , otherwise specify Angioimmunoblastic Tcell lymphoma Anaplastic large cell lymphoma , Anaplastic lymphoma kinase positive ( ALK ) + Anaplastic large cell lymphoma , ALK â€¢ Participants unavailable history ( lose , empty recoverable ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>